Summit Therapeutics (SUMM)

 

SUMM Share PerformanceMore

52 week high262.00 04/10/16
52 week low82.75 04/03/16
52 week change 21.50 (15.81%)
4 week volume988,282 21/12/16

Media for (SUMM)

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Summit Therapeutics plc : 3rd Quarter Results

Summit Therapeutics plc: 3rd Quarter Results Summit Therapeutics plc ('Summit', the 'Company' or the 'Group') SUMMIT THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED 31 OCTOBER 2016 AND OPERATIONAL PROGRESS Oxford, UK, 15 December 2016 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), th...

Summit Therapeutics plc : Notice of Results

Summit Therapeutics plc: Notice of Results Summit Therapeutics plc ("Summit" or the "Company") SUMMIT THERAPEUTICS TO REPORT FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED 31 OCTOBER 2016 ON 15 DECEMBER 2016 Oxford, UK, 13 December 2016 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), the drug discovery a...

Summit Enrolls Patients in the US into PhaseOut DMD, a Phase 2 Clinical Trial of Ezutromid

Summit Enrolls Patients in the US into PhaseOut DMD, a Phase 2 Clinical Trial of Ezutromid Summit Therapeutics plc ("Summit" or "the Company") SUMMIT ENROLS PATIENTS IN THE UNITED STATES INTO PhaseOut DMD, A PHASE 2 CLINICAL TRIAL OF EZUTROMID IN PATIENTS WITH DMD Oxford, UK, 16 November 2016 - Summit Therapeu...

Summit Therapeutics plc : Exercise of Options

Summit Therapeutics plc: Exercise of Options Summit Therapeutics plc ("Summit" or the "Company") EXERCISE OF SHARE OPTIONS Oxford, UK, 24 October 2016 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and C. difficile infection, announc...

Summit Therapeutics plc : Holding(s) in Company

Summit Therapeutics plc: Holding(s) in Company TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Summit Therapeutics PLC Sedol BN40HZ0 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting r...

Summit Therapeutics plc : Exercise of Options

Summit Therapeutics plc: Exercise of Options Summit Therapeutics plc ("Summit" or the "Company") EXERCISE OF SHARE OPTIONS Oxford, UK, 14 October 2016 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and C. difficile infection, announc...

Summit Therapeutics plc : Exercise of Options

Summit Therapeutics plc: Exercise of Options Summit Therapeutics plc ("Summit" or the "Company") EXERCISE OF SHARE OPTIONS Oxford, UK, 11 October 2016 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and C. difficile infection, announce...

Summit Therapeutics plc : Exercise of Options

Summit Therapeutics plc: Exercise of Options Summit Therapeutics plc ("Summit" or the "Company") EXERCISE OF SHARE OPTIONS Oxford, UK, 7 October 2016 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and C. difficile infection, announce...

Fundamental DataMore

EPS-41
Dividend yield0 %

Latest discussion posts More

  • Wow!

    At this rate SUMM sp will end 2017 lower than it started. AFAIK the drivers for 2017 will be the C-Dif Riddy drug comparison study as against Fidoximicin and that should be Q1 ...
    13-Dec-2016
    bobsson
  • Re: Rabbit out of hat?

    I have just researched my posts for SUMM and found the following. 10-07-14 Hold Consolidation The MP Word - Consolidation = Synonym = amalgamate, ...
    4-Oct-2016
    The MP
  • Re: Rabbit out of hat?

    Forgot the strong buy!
    4-Oct-2016
    alltold9

Users' HoldingsMore

Users who hold Summit Therapeutics also hold..
LLOYDS GRP.20%
RANGE RES.18%
ROYAL BANK SCOT15%
SIRIUS MINERALS14%
TESCO13%

Codes & Symbols

ISINGB00BN40HZ01
SymbolsSUMM, LSE:SUMM, SUMM.L, SUMM:LN, LON:SUMM, XLON:SUMM